Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER_GOV × Thoracic × Clear all

Phase

Phase 2 81 Phase NA 37 Phase 3 15 Phase 1/2 10 Phase 1 8 Phase 4 6 Phase EARLY_PHASE1 3 Phase 2/3 1

Status

Sponsor Class

OTHER 77 INDUSTRY 49 NETWORK 9 NIH 5 UNKNOWN 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Gynecologic 4 Breast 4 Other hematologic neoplasm 2 Genitourinary 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1 Head & Neck 1 CNS 1

Conditions

Weight Loss 1 Lung Neoplasms 1

Interventions

Nutrition Assessment 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01048970 2010-01-14

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

National Institute of Cancerología

Phase 2/3 Unknown

Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡